Advertisement
Advertisement
-
Business /

Investor Relations

Overseas capital tends to cherry-pick a few big-cap pharmaceutical companies rather than buy the biotech sector broadly, according to an analyst. Photo: Handout
Banking & finance

China investors energise Hong Kong biotech stocks. Is foreign money missing out?

Stock Connect reshuffle reflects biotech sector’s growing role on international stage, though overseas funds remain cautious.

IPO

Hong Kong’s IPO pace picks up as 2 mainland Chinese firms get listing approval

Insilico

Insilico Medicine advances Middle East push with UAE AI drug discovery deal

Made in China 2025

China biotech outlicensing tops US$52 billion in first 2 months

The latest deals are Sino Biopharmaceutical’s partnership with France’s Sanofi and Antengene’s agreement with Belgium’s UCB.

The logo of Sino Biopharmaceutical is seen on a building in Beijing, April 22, 2021. Photo: VCG via Getty Images
The logo of Sino Biopharmaceutical is seen on a building in Beijing, April 22, 2021. Photo: VCG via Getty Images
IPO

HSBC chairman floats ‘IPO connect’ for Hong Kong, Shenzhen listings

Modelled on Stock Connect, the proposal would give investors in the Greater Bay Area cross-border access to new share listings.

Hong Kong stock market

The big cornerstone comeback: what’s driving investors back to Hong Kong IPOs?

After four subdued years, the cornerstone investors that anchor Hong Kong’s IPO market are returning in force, reshaping the deal landscape.

Advertisement
Advertisement
Advertisement
China stock market

US investors increase buying of Hong Kong, mainland Chinese stocks

American investors bought US$15 billion of Hong Kong and mainland stocks in 2025, as buying picked up steam through the year.

A man walks on illuminated stairs at M+ Museum in West Kowloon as Hong Kong’s skyline is seen in a reflection on May 28, 2025. Photo: Eugene Lee
A man walks on illuminated stairs at M+ Museum in West Kowloon as Hong Kong’s skyline is seen in a reflection on May 28, 2025. Photo: Eugene Lee
Hong Kong stock market

Hong Kong stocks retreat on AI worries, China markets rally in Year of the Horse

Tech heavyweights drag Hong Kong stocks lower as investors fret over AI disruption following Wall Street’s decline.

Hong Kong stock market

Hong Kong stocks gain by most in nearly a month on China export optimism

‘China and Hong Kong are the biggest beneficiaries’ of US court decision on tariffs, Goldman Sachs strategists and economists say.

Hong Kong stock market

Hong Kong stocks fall as market reopens after 3-day Lunar New Year holiday

Tech heavyweights Alibaba, Baidu and Kuaishou drop as trading commences in the Year of the Horse.

Hong Kong stock exchange in Central. Photo: Jonathan Wong
Hong Kong stock market

Hong Kong stocks rise to wrap up best lunar-year performance in eight years

As market closes for Lunar New Year, benchmark hits 32 per cent gain since the Year of the Snake began in January 2025.

A sign in Central shows Hong Kong stock information on February 6, 2026. Photo: Jonathan Wong
A sign in Central shows Hong Kong stock information on February 6, 2026. Photo: Jonathan Wong
Hong Kong stock market

Korean investors pour US$92.5 million into Hong Kong AI, tech stocks

Return to mainland equities bends towards start-ups and ETFs, versus earlier focus on bellwether, large-cap names.

Hong Kong stock market

Hong Kong stocks slip as regulator summons tech firms over train tickets

Approaching Lunar New Year holiday also dampens investors’ enthusiasm for technology stocks, analyst says.

IPO

Shenzhen-listed Unisplendour abandons plan to raise funds in Hong Kong

The Tsinghua Holdings arm, however, will raise US$800 million via a private share placement on Shenzhen exchange.

Unisplendour was expected to raise US$1 billion from its Hong Kong share sale this year. Photo: Reuters
Hong Kong stock market

Hong Kong stocks rise as positive holiday bias sets in ahead of Lunar New Year

Southbound net inflows reflect investor optimism about Hong Kong stocks after the holiday, analyst says.

Bull statues look out over Exchange Square, where Hong Kong’s bourse operator is headquartered, on February 3, 2026. Photo: Reuters
Bull statues look out over Exchange Square, where Hong Kong’s bourse operator is headquartered, on February 3, 2026. Photo: Reuters
Made in China 2025

Chinese healthcare firms expand overseas to support growing expat community

Privately owned Distinct Healthcare plans to open a clinic in Dubai, while TCM group Gushengtang eyes 50 centres in Southeast Asia.

Banking & finance

Mainland China’s investors pour into Hong Kong-listed drug stocks

An index tracking Stock Connect buying of 40 mainland drug firms gains 9 per cent in a week as China’s industry heft grows.

Advertisement
Advertisement
Advertisement
Hong Kong

AI chip supplier Axera trades flat in Hong Kong debut as investor frenzy cools

Axera attracted HK$22.34 billion from retail investors during the bookbuilding period, marking an oversubscription of 74.4 times.

Axera specialises in designing AI perception and edge computing chips for applications such as smart vehicles. Photo: Handout
Axera specialises in designing AI perception and edge computing chips for applications such as smart vehicles. Photo: Handout
Banking & finance

China slashes wait times for loss-making tech firms seeking refinancing, fundraising

Three of China’s stock exchanges have relaxed fundraising time thresholds on listed tech companies as Beijing pushes for self-reliance.

videocam
Hong Kong stock market

Tech sell-off rattles investors with cross-asset volatility set to linger

Markets swing sharply across asset classes as AI forces a rethink of pricing power and long-term growth bets.

Made in China 2025

Fosun Pharma unit licenses lung cancer drug to Eisai in US$1.55 billion deal

The deal comes as Chinese novel drug makers are having more say in how their new medicines are developed with global partners.

A view of the Shanghai facility of Fosun Pharma’s biopharma unit Henlius. Photo: Handout
Hong Kong stock market

Hong Kong stocks drop as mainland tech firms, metals and crypto slide

Hang Seng Index follows US declines as AI worries and falling prices for gold, silver and cryptocurrency rattle investors.

A view of Exchange Square, home of bourse operator Hong Kong Exchanges and Clearing, on December 30, 2025. Photo: Sun Yeung
A view of Exchange Square, home of bourse operator Hong Kong Exchanges and Clearing, on December 30, 2025. Photo: Sun Yeung
IPO

China’s biggest pork producer Muyuan flat in Hong Kong share debut

Firm’s US$1.4 billion IPO records lower oversubscription rate than other recent listings, reflecting a cooling of the red-hot market.

Hong Kong stock market

Hong Kong stocks eke out gain as mainland investors overpower tech jitters

Southbound Stock Connect inflows provide late-session support, helping the benchmark reverse earlier losses.

IPO

Morgan Stanley sees another record year for Hong Kong IPOs as pipeline hits 450

Mainland China’s issuers will still dominate city’s IPO market, executive says, but US and Southeast Asian companies are also joining in.

Mainland China’s issuers will still dominate city’s IPO market, Morgan Stanley executive says. Photo: Reuters
Help preserve 120 years of quality journalism.
SUPPORT NOW